药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Meticillin
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Ivosidenib.
Meticillin
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Ivosidenib.
Meticillin
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Ivosidenib.
Meticillin
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Ivosidenib.
Meticillin
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Ivosidenib.
Meticillin
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Ivosidenib.
Meticillin
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Ivosidenib.
Meticillin
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Ivosidenib.
Meticillin
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Ivosidenib.
Meticillin
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Ivosidenib.
Meticillin
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Ivosidenib.
Meticillin
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Ivosidenib.
Meticillin
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Ivosidenib.
Meticillin
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Ivosidenib.
Meticillin
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Ivosidenib.
Meticillin
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Ivosidenib.
Meticillin
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Ivosidenib.
Meticillin
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Ivosidenib.
Meticillin
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Ivosidenib.
Meticillin
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Ivosidenib.